4.7 Article

Developing practice recommendations for endovascular revascularization for acute ischemic stroke

期刊

NEUROLOGY
卷 79, 期 13, 页码 S243-S255

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e31826959fc

关键词

-

资金

  1. Cerevast Therapeutics, Inc.
  2. NINDS
  3. Therapeutic Methods and Apparatus for Use of Sonication
  4. NIH/NINDS
  5. Novartis, Inc.
  6. Hoffman-La Roche Ltd
  7. Takeda Pharmaceuticals
  8. Ohio Department of Health
  9. Genentech, Inc.
  10. NIH
  11. AHA
  12. Department of Defense
  13. NIH (NINDS)
  14. Mayfield Education and Research Fund
  15. Concentric Medical
  16. Medical University of South Carolina/NIH study
  17. Society of Vascular & Interventional Neurology (SVIN)

向作者/读者索取更多资源

Guidelines have been established for the management of acute ischemic stroke; however, specific recommendations for endovascular revascularization therapy are lacking. Burgeoning investigation of endovascular revascularization therapies for acute ischemic stroke, rapid device development, and a diverse training background of the providers performing the procedures underscore the need for practice recommendations. This review provides a concise summary of the Society of Vascular and Interventional Neurology endovascular acute ischemic stroke roundtable meeting. This document was developed to review current clinical efficacy of pharmacologic and mechanical revascularization therapy, selection criteria, periprocedure management, and endovascular time metrics and to highlight current practice patterns. It therefore provides an outline for the future development of multisociety guidelines and recommendations to improve patient selection, procedural management, and organizational strategies for revascularization therapies in acute ischemic stroke. Neurology (R) 2012;79 (Suppl 1):S243-S255

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据